ADVERTISEMENT
970x220
Manila Bulletin devider Entertainment devider Celebrities devider ENHYPEN's agency warns against unauthorized fan event in PH

ENHYPEN's agency warns against unauthorized fan event in PH

Published Jan 5, 2023 09:24 am

The management of K-pop boy band ENHYPEN has issued a warning against an unauthorized event that will be held in the Philippines on Jan. 7.

In a notice issued on Jan. 5 titled “Caution: ENHYPEN-Related Unauthorized Event in the Philippines,” Belift Lab said the “ENHAFESTIVAL: DAY 1” that will be held in the Philippines on Jan. 7 is without permission.

K-pop boy band ENHPEN (Belift Lab)

The festival kit for ENHAFESTIVAL (Photos from ENHAFESTIVAL on Facebook)

“We would like to thank all ENGENEs for your unwavering love towards ENHYPEN. We would like to inform you about the paid event using ENHYPEN’s IP without our company’s authorization. We advise you not to get adversely affected by the event,” it said.

Belift Lab listed the name of the event:

Event name: ENHAFESTIVAL: DAY 1

Date: Saturday, January 7, 2023

Location: MANILA

Official website: https://www.facebook.com/enhafestivalday1

According to the ENHAFESTIVAL: DAY 1 Facebook page, it is an “An ENHYPEN OT7 Photo Exhibition in MANILA” that will be held at Avida Towers Centera Clubhouse.

Tickets are priced at P400 with festival kit and P300 for entrance only.

“This event is an unauthorized paid event that sold tickets by using the content of BELIFT LAB without our authorization. If the event host pushes ahead with this event, we will take legal actions for infringement of intellectual property,” the agency warned.

It added, “We would like to take this opportunity to highlight that this is an unauthorized event being held without any discussions with our company. BELIFT LAB assumes no responsibility for any damage resulting from the event. We will continue to work to ensure that the rights of our artists are fully protected.”

The organizers of ENHAFESTIVAL have not released a statement as of this writing.

Related Tags

Belift Lab ENHYPEN
ADVERTISEMENT
300x250
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0 72px 0 12px; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } li:empty { display: none; } .hidden { display: none; }
function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // The two offset values // changed to 10 from 1 , 2 const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } function isNearBottom() { return window.innerHeight + window.scrollY >= document.documentElement.scrollHeight - 100; } function onScroll() { if (isLoading) return; // Skip if already loading if (isNearBottom()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; // Set flag to prevent multiple calls const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { loadCount++; // Increment only after successful execution }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; // Reset flag after execution }); } } window.addEventListener("scroll", onScroll); }); // Mutation Observer for Newly Loaded Articles const observer = new MutationObserver(() => { const articles = document.querySelectorAll(".articles-observe"); if (articles.length > 0) { observeArticles(articles); } }); observer.observe(document.body, { childList: true, subtree: true }); // Intersection Observer for Updating URL function observeArticles(articles) { const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); } } }); }, { threshold: 0.1 } ); articles.forEach(article => intersectionObserver.observe(article)); }
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.